// company-profile

Recursion Pharmaceuticals, Inc.

RXRX
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings293Insiders18
// api This Recursion Pharmaceuticals, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 7 insiders purchased shares versus 1 sale. Buying was led by Li Dean Y.

// 90-day insight

Over the last 90 days, Recursion Pharmaceuticals, Inc. insiders bought $0 (9 transactions) and sold $583K (6 transactions).

  • Most active insider: Gibson Christopher with 17 transactions totaling $741K.
  • Largest single sale: $191K by Khan Najat on May 15, 2026.
  • 65% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Recursion Pharmaceuticals, Inc. as of 2026-03-31

↓ decreasing
Total reported AUM
$959.5M
QoQ change
-20.7%
Reporting period
2026-03-31
#1
ARK Investment Management LLC
CIK 1697748
$123.5M
40.2M shares
#2
STATE STREET CORP
CIK 93751
$87.5M
28.5M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
CIK 2100119
$68.3M
22.2M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 18, 2026Bumpus NamandjeRXRX
Sale10b5
3,963$3.18$13K
Jun 17, 2026Li Dean YRXRX
Award
88,424$0.00$0K
Jun 17, 2026Bumpus NamandjeRXRX
Award
88,424$0.00$0K
Jun 17, 2026Michor FranziskaRXRX
Award
88,424$0.00$0K
Jun 17, 2026Borgeson BlakeRXRX
Award
88,424$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.